RADX Independent Test Assessment Program for MPOX Lesion Panel - Commercialization Center

MPOX 病变组的 RADX 独立测试评估计划 - 商业化中心

• 批准号: 10941137
• 负责人: MARK MARINO
• 金额: $ 65.98万
• 依托单位: VENTUREWELL
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-27 至 2024-09-26
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10941137
• 关键词: Acceleration; Development; Diagnostic tests; Lesion; Monkeypox; RADx Tech; Testing; United States National Institutes of Health; commercialization; programs; Acceleration; Development; Diagnostic tests; Lesion; Monkeypox; RADx Tech; Testing; United States National Institutes of Health; commercialization; programs

The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program has established the Independent Test Assessment Program (ITAP) in order to accelerate regulatory review and availability of high-quality, accurate, and reliable diagnostic tests.

国家卫生研究院（NIH）诊断迅速加速（RADX®）技术计划已建立了独立的测试评估计划（ITAP），以便加快监管审查和高质量，准确且可靠的诊断测试的可用性。